Acro Biomedical (ACBM) Non-Current Assets (2017 - 2025)

Acro Biomedical's Non-Current Assets history runs 9 years deep, the most recent figure standing at $13651.0 for Q2 2025.

• In Q2 2025, Non-Current Assets fell 69.22% year-over-year to $13651.0; the TTM figure through Dec 2025 stood at $33975.0 (down 78.75% YoY), while the FY2024 annual figure was $26898.0, down 52.67% from the prior year.
• Non-Current Assets was $13651.0 for Q2 2025 at Acro Biomedical, down from $20324.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $56833.0 in Q4 2023 to a low of $6268.0 in Q3 2021.
• Historically, Non-Current Assets has averaged $29931.8 across 5 years, with a median of $28423.5 in 2022.
• The sharpest annual moves came in 2021 and 2024: Non-Current Assets slumped 82.07% in 2021, then soared 481.9% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $54662.0 in 2021, then sank by 45.21% to $29949.0 in 2022, then jumped by 89.77% to $56833.0 in 2023, then sank by 52.67% to $26898.0 in 2024, then sank by 49.25% to $13651.0 in 2025.
• The last three Non-Current Assets figures came in at $13651.0 (Q2 2025), $20324.0 (Q1 2025), and $26898.0 (Q4 2024), per Business Quant data.